Research of second line anti-diabetes drug for patients with Type-2 diabetes who received Sitagliptin as first line.
Not Applicable
- Conditions
- Type II diabetes mellitus
- Registration Number
- JPRN-UMIN000014467
- Lead Sponsor
- Fukuoka Tokushukai Medical Center Psychosomatic Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 132
Inclusion Criteria
Not provided
Exclusion Criteria
Moderate to severe renal dysfunction Dialysis patient Medical history of heart failure,bowel obstruction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change and rate of change in HbA1c , 24 weeks later.
- Secondary Outcome Measures
Name Time Method